跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SERENACE INJECTION haloperidol 5 mg/mL ampoule 1mL - TGA Drug Approval Details
Approvals
/
TGA
/
SERENACE INJECTION haloperidol 5 mg/mL ampoule 1mL
Approved
STANDARD
SERENACE INJECTION haloperidol 5 mg/mL ampoule 1mL
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
5a047db332c1a0be
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
5a047db332c1a0be
Product Name
SERENACE INJECTION haloperidol 5 mg/mL ampoule 1mL
Artg Id
188367
Artg Name
SERENACE INJECTION haloperidol 5 mg/mL ampoule 1mL
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
2011-10-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/3aee979901b3af6fb09008f50afb296c.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/658c70549251c7bc5c99624d21f534be.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
5a047db332c1a0be
Type
Standard
Back to TGA Approvals